{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:26:33Z","timestamp":1792207593613,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00277-020-03918-6","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T05:55:21Z","timestamp":1582178121000},"page":"799-808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-4646","authenticated-orcid":false,"given":"Mariana","family":"Bastos-Oreiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Munta\u00f1ola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Panizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonzalez-Barca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Gonz\u00e1lez","family":"de Villambrosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Lu\u00eds Bello","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Gonz\u00e1lez-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Terol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Iserte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Salar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Luzardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Garc\u00eda-Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Vida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Queizan-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Penarrubia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Cruz","family":"Viguria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Pardal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pe\u00f1alver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"L\u00f3pez-Guillermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"issue":"20","key":"3918_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"key":"3918_CR2","doi-asserted-by":"crossref","unstructured":"(1982) National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: summary and description of a working formulation for clinical usage. The non-Hodgkin\u2019s lymphoma pathologic classification project. Cancer 49(10):2112\u20132135","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"issue":"15","key":"3918_CR3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMra0807082","volume":"362","author":"G Lenz","year":"2010","unstructured":"Lenz G, Staudt LM (2010) Aggressive lymphomas. N Engl J Med 362(15):1417\u20131429","journal-title":"N Engl J Med"},{"issue":"23","key":"3918_CR4","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma E-J, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, M\u00fcller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM, Lymphoma\/Leukemia Molecular Profiling Project (2006) Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med 354(23):2431\u20132442","journal-title":"N Engl J Med"},{"issue":"21","key":"3918_CR5","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA, Davies AJ, Norton AJ, Muller-Hermelink HK, Ott G, Campo E, Montserrat E, Wilson WH, Jaffe ES, Simon R, Yang L, Powell J, Zhao H, Goldschmidt N, Chiorazzi M, Staudt LM (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351(21):2159\u20132169","journal-title":"N Engl J Med"},{"issue":"4","key":"3918_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ejca.2007.12.016","volume":"44","author":"M Sant","year":"2008","unstructured":"Sant M, Allemani C, De Angelis R, Carbone A, de Sanjos\u00e8 S, Gianni AM et al (2008) Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States. Eur J Cancer 44(4):579\u2013587","journal-title":"Eur J Cancer"},{"issue":"Suppl 5","key":"3918_CR7","doi-asserted-by":"publisher","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","volume":"14","author":"M Sant","year":"2003","unstructured":"Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J et al (2003) EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol 14(Suppl 5):v61\u2013v118","journal-title":"Ann Oncol"},{"issue":"5","key":"3918_CR8","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386","journal-title":"Int J Cancer"},{"issue":"4","key":"3918_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5694\/mja17.00937","volume":"209","author":"F Wright","year":"2018","unstructured":"Wright F, Hapgood G, Loganathan A, Dunn N, Philpot S, Moore J, Mollee P (2018) Relative survival of patients with lymphoma in Queensland according to histological subtype. Med J Aust 209(4):166\u2013172","journal-title":"Med J Aust"},{"issue":"1","key":"3918_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cll.2017.10.007","volume":"38","author":"T Tomoka","year":"2018","unstructured":"Tomoka T, Montgomery ND, Powers E, Dhungel BM, Morgan EA, Mulenga M et al (2018) Lymphoma and pathology in sub-Saharan Africa: current approaches and future directions. Clin Lab Med 38(1):91\u2013100","journal-title":"Clin Lab Med"},{"issue":"4","key":"3918_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"164","author":"D Chihara","year":"2014","unstructured":"Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, Tomotaka S, Morton LM, Weisenburger DD, Matsuo K (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164(4):536\u2013545","journal-title":"Br J Haematol"},{"issue":"8","key":"3918_CR12","first-page":"669","volume":"48","author":"Y Yuan","year":"2014","unstructured":"Yuan Y, Yang L, Sun T, Li H, Zhu J, Song Y, Wang N (2014) Analysis of lymphoma incidence in Beijing, 1998-2010. Zhonghua Yu Fang Yi Xue Za Zhi 48(8):669\u2013673","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"1","key":"3918_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 107(1):265\u2013276","journal-title":"Blood."},{"issue":"4","key":"3918_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/CEJ.0b013e328339e2f3","volume":"19","author":"R Marcos-Gragera","year":"2010","unstructured":"Marcos-Gragera R, Cervantes-Amat M, Vicente ML, de Sanjos\u00e9 S, Guallar E, Godoy C, Calvo C, Giraldo P, Sant M, Peris-Bonet R, Carmen Martos M (2010) Population-based incidence of childhood leukaemias and lymphomas in Spain (1993-2002). Eur J Cancer Prev 19(4):247\u2013255","journal-title":"Eur J Cancer Prev"},{"issue":"11","key":"3918_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.medcli.2014.03.037","volume":"144","author":"JA Rodr\u00edguez-Garc\u00eda","year":"2015","unstructured":"Rodr\u00edguez-Garc\u00eda JA, V\u00e1zquez L, Ramos F, Cuevas B, Mart\u00edn A, Smucler A et al (2015) Incidence of haematological neoplasms in Castilla y Le\u00f3n, Spain. Med Clin (Barc) 144(11):491\u2013500","journal-title":"Med Clin (Barc)"},{"issue":"19","key":"3918_CR16","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","volume":"116","author":"M Sant","year":"2010","unstructured":"Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O et al (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 116(19):3724\u20133734","journal-title":"Blood."},{"issue":"9","key":"3918_CR17","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/bjc.2015.94","volume":"112","author":"A Smith","year":"2015","unstructured":"Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, Patmore R, Jack A, Roman E (2015 Apr 28) Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK\u2019s haematological malignancy research network. Br J Cancer 112(9):1575\u20131584","journal-title":"Br J Cancer"},{"issue":"4","key":"3918_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3109\/10428194.2014.956315","volume":"56","author":"M Dandoit","year":"2015","unstructured":"Dandoit M, Mounier M, Guy J, Petrella T, Girard S, Casasnovas R-O, Martin L, Bonnetain F, Maynadi\u00e9 M (2015) The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry. Leuk Lymphoma 56(4):1050\u20131057","journal-title":"Leuk Lymphoma"},{"key":"3918_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR (2016) 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66:443","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3918_CR20","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","volume":"101","author":"AM Perry","year":"2016","unstructured":"Perry AM, Diebold J, Nathwani BN, MacLennan KA, M\u00fcller-Hermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD (2016) Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the international non-Hodgkin lymphoma classification project. Haematologica. 101(10):1244\u20131250","journal-title":"Haematologica."},{"key":"3918_CR21","doi-asserted-by":"crossref","unstructured":"(1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The non-Hodgkin\u2019s lymphoma classification project. Blood. 89(11):3909\u20133918","DOI":"10.1182\/blood.V89.11.3909"},{"issue":"1","key":"3918_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bjh.12730","volume":"165","author":"MO Khalil","year":"2014","unstructured":"Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD et al (2014) Incidence of marginal zone lymphoma in the United States, 2001\u20132009 with a focus on primary anatomic site. Br J Haematol 165(1):67\u201377","journal-title":"Br J Haematol"},{"issue":"11","key":"3918_CR23","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1093\/annonc\/mdu443","volume":"25","author":"JS Abramson","year":"2014","unstructured":"Abramson JS, Feldman T, Kroll-Desrosiers AR, Muffly LS, Winer E, Flowers CR, Lansigan F, Nabhan C, Nastoupil LJ, Nath R, Goy A, Castillo JJ, Jagadeesh D, Woda B, Rosen ST, Smith SM, Evens AM (2014) Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy. Ann Oncol 25(11):2211\u20132217","journal-title":"Ann Oncol"},{"issue":"6","key":"3918_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11899-016-0355-9","volume":"11","author":"BM Haverkos","year":"2016","unstructured":"Haverkos BM, Pan Z, Gru AA, Freud AG, Rabinovitch R, Xu-Welliver M, Otto B, Barrionuevo C, Baiocchi RA, Rochford R, Porcu P (2016 Dec) Extranodal NK\/T-cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in north American and European cases. Curr Hematol Malig Rep 11(6):514\u2013527","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"3918_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/01.pai.0000205062.27174.56","volume":"15","author":"C Barrionuevo","year":"2007","unstructured":"Barrionuevo C, Zaharia M, Martinez MT, Taxa L, Misad O, Moscol A et al (2007) Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol 15(1):38\u201344","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"17","key":"3918_CR26","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"W Au","year":"2009","unstructured":"Au W, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim W-S, Sng I, Vose J, Armitage JO, Liang R, International Peripheral T-Cell Lymphoma Project (2009) Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the international peripheral T-cell lymphoma project. Blood. 113(17):3931\u20133937","journal-title":"Blood."},{"issue":"9","key":"3918_CR27","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1089\/aid.2013.0128","volume":"30","author":"A Trevi\u00f1o","year":"2014","unstructured":"Trevi\u00f1o A, Alcantara LC, Benito R, Caballero E, Aguilera A, Ramos JM et al (2014) Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain. AIDS Res Hum Retrovir 30(9):856\u2013862","journal-title":"AIDS Res Hum Retrovir"},{"issue":"12","key":"3918_CR28","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1097\/QAD.0000000000001527","volume":"31","author":"C de Mendoza","year":"2017","unstructured":"de Mendoza C, Caballero E, Aguilera A, Requena S, de Lejarazu RO, Pir\u00f3n M et al (2017) Human T-lymphotropic virus type 1 infection and disease in Spain. AIDS 31(12):1653\u20131663","journal-title":"AIDS"},{"issue":"1","key":"3918_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018 Jan) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"3918_CR30","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin\u2019s disease. International prognostic factors project on advanced Hodgkin\u2019s disease. N Engl J Med 339(21):1506\u20131514","journal-title":"N Engl J Med"},{"issue":"12","key":"3918_CR31","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1093\/annonc\/mdt413","volume":"24","author":"B Klimm","year":"2013","unstructured":"Klimm B, Goergen H, Fuchs M, von Tresckow B, B\u00f6ll B, Meissner J et al (2013) Impact of risk factors on outcomes in early-stage Hodgkin\u2019s lymphoma: an analysis of international staging definitions. Ann Oncol 24(12):3070\u20133076","journal-title":"Ann Oncol"},{"key":"3918_CR32","doi-asserted-by":"crossref","unstructured":"B\u00f6ll B, G\u00f6rgen H (2019) The treatment of older Hodgkin lymphoma patients Br J Haematol 184(1):82\u201392","DOI":"10.1111\/bjh.15652"},{"issue":"2","key":"3918_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5858\/arpa.2013-0674-RA","volume":"139","author":"JK Frederiksen","year":"2015","unstructured":"Frederiksen JK, Sharma M, Casulo C, Burack WR (2015) Systematic review of the effectiveness of fine-needle aspiration and\/or core needle biopsy for subclassifying lymphoma. Arch Pathol Lab Med 139(2):245\u2013251","journal-title":"Arch Pathol Lab Med"},{"issue":"9759","key":"3918_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","volume":"377","author":"G Salles","year":"2011","unstructured":"Salles G, Seymour JF, Offner F, L\u00f3pez-Guillermo A, Belada D, Xerri L, Feugier P, Bouabdallah R, Catalano JV, Brice P, Caballero D, Haioun C, Pedersen LM, Delmer A, Simpson D, Leppa S, Soubeyran P, Hagenbeek A, Casasnovas O, Intragumtornchai T, Ferm\u00e9 C, da Silva MG, Sebban C, Lister A, Estell JA, Milone G, Sonet A, Mendila M, Coiffier B, Tilly H (2011) Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet. 377(9759):42\u201351","journal-title":"Lancet."},{"issue":"15","key":"3918_CR35","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1182\/blood-2017-07-795302","volume":"130","author":"A Salar","year":"2017","unstructured":"Salar A, Domingo-Domenech E, Panizo C, Nicol\u00e1s C, Bargay J, Munta\u00f1ola A et al (2017) Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma. Blood 130(15):1772\u20131774","journal-title":"Blood"},{"issue":"4","key":"3918_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, van den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235\u2013242","journal-title":"N Engl J Med"},{"issue":"12","key":"3918_CR37","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","volume":"121","author":"H Horn","year":"2013","unstructured":"Horn H, Ziepert M, Becher C, Barth TF, Bernd HW, Feller AC, Klapper W, Hummel M, Stein H, Hansmann ML, Schmelter C, M\u00f6ller P, Cogliatti S, Pfreundschuh M, Schmitz N, Tr\u00fcmper L, Siebert R, Loeffler M, Rosenwald A, Ott G, German High-Grade Non-Hodgkin Lymphoma Study Group (2013) MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood. 121(12):2253\u20132263","journal-title":"Blood."},{"issue":"11","key":"3918_CR38","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/cncr.25765","volume":"117","author":"PJ Shenoy","year":"2011","unstructured":"Shenoy PJ, Malik N, Nooka A, Sinha R, Ward KC, Brawley OW, Lipscomb J, Flowers CR (2011) Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer. 117(11):2530\u20132540","journal-title":"Cancer."},{"issue":"1","key":"3918_CR39","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Bri\u00e8re J, Haioun C, Cazals-Hatem D, Bosly A, Xerri L, Tilly H, Berger F, Bouhabdallah R, Diebold J (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA). Blood. 92(1):76\u201382","journal-title":"Blood."},{"issue":"2","key":"3918_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, Harris NL, Jaffe ES, Pileri SA, Savage KJ, Weisenburger DD, Armitage JO, Mounier N, Vose JM (2013) Clinicopathologic characteristics of angioimmunoblastic T cell lymphoma: analysis of the international peripheral T cell lymphoma project. J Clin Oncol 31(2):240\u2013246","journal-title":"J Clin Oncol"},{"issue":"32","key":"3918_CR41","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1200\/JCO.2012.42.2345","volume":"30","author":"D Sibon","year":"2012","unstructured":"Sibon D, Fournier M, Bri\u00e8re J, Lamant L, Haioun C, Coiffier B, Bologna S, Morel P, Gabarre J, Hermine O, Sonet A, Gisselbrecht C, Delsol G, Gaulard P, Tilly H (2012) Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte trials. J Clin Oncol 30(32):3939\u20133946","journal-title":"J Clin Oncol"},{"issue":"18","key":"3918_CR42","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1200\/JCO.2016.70.9410","volume":"35","author":"S Sasse","year":"2017","unstructured":"Sasse S, Br\u00f6ckelmann PJ, Goergen H, Pl\u00fctschow A, M\u00fcller H, Kreissl S, Buerkle C, Borchmann S, Fuchs M, Borchmann P, Diehl V, Engert A (2017) Long-term follow-up of contemporary treatment in early-stage Hodgkin lymphoma: updated analyses of the German Hodgkin study group HD7, HD8, HD10, and HD11 trials. J Clin Oncol 35(18):1999\u20132007","journal-title":"J Clin Oncol"},{"key":"3918_CR43","first-page":"CD007941","volume":"5","author":"N Skoetz","year":"2017","unstructured":"Skoetz N, Will A, Monsef I, Brillant C, Engert A, von Tresckow B (2017) Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database Syst Rev 5:CD007941","journal-title":"Cochrane Database Syst Rev"},{"key":"3918_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1600-0609.2005.00462.x","volume":"66","author":"L Nogov\u00e1","year":"2005","unstructured":"Nogov\u00e1 L, Reineke T, Josting A, M\u00fcller-Hermelink HK, Eich HT, Behringer K et al (2005) Lymphocyte-predominant and classical Hodgkin\u2019s lymphoma--comparison of outcomes. Eur J Haematol Suppl 66:106\u2013110","journal-title":"Eur J Haematol Suppl"},{"key":"3918_CR45","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.2169\/internalmedicine.0990-18","volume":"57","author":"A Tanimura","year":"2018","unstructured":"Tanimura A, Hirai R, Nakamura M, Takeshita M, Hagiwara S, Miwa A (2018) The prognostic impact of dose-attenuated R-chop therapy for elderly patients with diffuse large B-cell lymphoma. Intern Med 57:3521","journal-title":"Intern Med"},{"issue":"6","key":"3918_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1470-2045(13)70122-0","volume":"14","author":"R Delarue","year":"2013","unstructured":"Delarue R, Tilly H, Mounier N, Petrella T, Salles G, Thieblemont C, Bologna S, Ghesqui\u00e8res H, Hacini M, Fruchart C, Ysebaert L, Ferm\u00e9 C, Casasnovas O, van Hoof A, Thyss A, Delmer A, Fitoussi O, Molina TJ, Haioun C, Bosly A (2013) Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial. Lancet Oncol 14(6):525\u2013533","journal-title":"Lancet Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03918-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-03918-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03918-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T19:19:26Z","timestamp":1613762366000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-03918-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3918"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-03918-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,20]]},"assertion":[{"value":"8 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies using animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"Informed consent was not obtained from the individual participants included in the study because the local ethics committee approved its omission, given the registry is completely anonymised and does not include personal patient data beyond age and sex or treatments administered.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}